Position in INVA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$473,641
+$17,750 QoQ
Shares Held
20,328
-10.9% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOKF, NA holds $12,079,082 across 17 Biotechnology names. INVA ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,935 | $2,650,214 | |
| 2 | EXEL |
Exelixis, Inc.
|
56,331 | $2,416,036 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
53,892 | $2,172,385 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,351 | $1,043,835 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
14,954 | $966,476 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
19,585 | $484,924 | |
| 7 | INVA |
Innoviva, Inc.
This page
|
20,328 | $473,641 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
1,829 | $472,467 |
All Filings in INVA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $473,641 | 20,328 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $455,891 | 22,806 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $418,436 | 22,928 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $461,527 | 22,973 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $483,400 | 26,663 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $497,042 | 28,648 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $540,814 | 28,007 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $760,582 | 46,377 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $251,932 | 16,531 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||